ask="16.00"
ask_size="200"
average_daily_volume="41800"
bid="6.42"
bid_size="200"
book_value="0.00"
change="-0.27"
change_from_200_day_moving_average="-0.92"
change_from_50_day_moving_average="-0.89"
change_from_52_week_high="-44.30"
change_From_52_week_low="0.71"
change_in_percent="-3.82%"
close="6.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.04"
ebitda="0.00"
eps_estimate_current_year="-1.07"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.41"
ex_dividend_date="N/A"
float_shares="N/A"
high="7.07"
high_52_weeks="51.10"
last_trade_date="1/3/2017"
last_trade_price="6.80"
last_trade_size="372"
last_trade_time="4:00pm"
low="6.56"
low_52_weeks="6.09"
market_capitalization="67.49B"
moving_average_200_day="7.72"
moving_average_50_day="7.69"
name="KalVista Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.64"
open="7.07"
pe_ratio="0.92"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-11.88%"
percent_change_from_50_day_moving_average="-11.63%"
percent_change_from_52_week_high="-86.69%"
percent_change_from_52_week_low="+11.66%"
previous_close="7.07"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9925000000"
short_ratio="0.00"
stock_exchange="NGM"
symbol="KALV"
volume="40799"
weeks_range_52="6.09 - 51.10"
